Characteristics of matrix metalloproteinases and their role in embryogenesis of the mammalian respiratory system
References
- Ala-aho R., Kähäri V.M.: Collagenases in cancer. Biochimie, 2005; 87: 273–286
- Andreeva A.V., Kutuzov M.A., Voyno-Yasenetskaya T.A.: Regulation of surfactant secretion in alveolar type II cells. Am. J. Physiol. Lung. Cell. Mol. Physiol., 2007; 293: L259–L271
- Anteby E.Y., Greenfield C., Natanson-Yaron S., Goldman-Wohl D., Hamani Y., Khudyak V., Ariel I., Yagel S.: Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9. Mol. Hum. Reprod., 2004; 10: 229–235
- Arza B., De Maeyer M., Félez J., Collen D., Lijnen H.R.: Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3). Eur. J. Biochem., 2001; 268: 826–831
- Atkinson J.J., Holmbeck K., Yamada S., Birkedal-Hansen H., Parks W.C., Senior R.M.: Membrane-type 1 matrix metalloproteinase is required for normal alveolar development. Develop. Dyn., 2005; 232: 1079–1090
- Batra J., Robinson J., Soares A.S., Fields A.P., Radisky D.C., Radisky E.S.: Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: Binding studies and crystal structure. J. Biol. Chem., 2012; 287: 15935–15946
- Batra J., Soares A.S., Mehner C., Radisky E.S.: Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes. PLoS One, 2013; 8: e75836
- Bauvois B.: New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression. Biochim. Biophys. Acta, 2012; 1825: 29–36
- Belokhvostova D., Berzanskyte I., Cujba A.M., Jowett G., Marshall L., Prueller J., Watt F.M.: Homeostasis, regeneration and tumour formation in the mammalian epidermis. Int. J. Dev. Biol., 2018; 62: 571–582
- Bland R.D., Nielson D.W.: Developmental changes in lung epithelial ion transport and liquid movement. Annu. Rev. Physiol., 1992; 54: 373–394
- Bolon I., Devouassoux M., Robert C., Moro D., Brambilla C., Brambilla E.: Expression of urokinase-type plasminogen activator, stromelysin-1, stromelysin-3 and matrilysin genes in lung carcinomas. Am. J. Pathol., 1997; 150: 1619–1629
- Boucherat O., Bourbon J.R., Barlier-Mur A.M., Chailley-Heu B., D’Ortho M.P., Delacourt C.: Differential expression of matrix metalloproteinases and inhibitors in developing rat lung mesenchymal and epithelial cells. Pediatr. Res., 2007; 62: 20–25
- Brauer P.R.: MMPs: Role in cardiovascular development and disease. Front. Biosci., 2006; 11: 447–478
- Brew K., Dinakarpandian D., Nagase H.: Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim. Biophys. Acta, 2000; 1477: 267–283
- Brew K., Nagase H.: The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity. Biochim. Biophys. Acta, 2010; 1803: 55–71
- Cauwe B., Opdenakker G.: Intracellular substrate cleavage: A novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol., 2010; 45: 351–423
- Chang Z.K., Meng F.G., Zhang Z.Q., Mao G.P., Huang Z.Y., Liao W.M., He A.S.: MicroRNA-193b-3p regulates matrix metalloproteinase 19 expression in interleukin-1β-induced human chondrocytes. J. Cell. Biochem., 2018; 119: 4775–4782
- Chetty C., Lakka S.S., Bhoopathi P., Kunigal S., Geiss R., Rao J.S.: Tissue inhibitor of matrix metalloproteinase 3 supresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer. Cancer. Res., 2008; 68: 4736–4745
- Crowther C.A., Alfirevic Z., Haslam R.R.: Prenatal thyrotropin-releasing hormone for preterm birth. Cochrane. Database. Syst. Rev., 2000; 2000: CD000019
- deMello D.E., Sawyer D., Galvin N., Reid L.M.: Early fetal development of lung vasculature. Am. J. Respir. Cell. Mol. Biol. 1997; 16: 568–581
- Deryugina E.I., Quigley J.P.: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev., 2006; 25: 9–34
- Elumalai G., Anbazhagan L.: “Laryngomalacia” embryological basis and its clinical significance. Elixir Embryology, 2016; 100: 43420–43424
- English W.R., Ireland-Zecchini H., Baker A.H., Littlewood T.D., Bennett M.R., Murphy G.: Tissue inhibitor of metalloproteinase-3 (TIMP-3) induces FAS dependent apoptosis in human vascular smooth muscle cells. PLoS One, 2018; 13: e0195116
- Erickson H.P.: Tenascin-C, tenascin-R and tenascin-X: A family of talented proteins in search of functions. Curr. Opin. Cell Biol., 1993; 5: 869–876
- Fic P., Zakrocka I., Kurzepa J., Stepulak A.: Matrix metalloproteinases and atherosclerosis. Postępy Hig. Med. Dośw., 2011; 65: 16–27
- Fink K., Boratyński J.: The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis. Postępy Hig. Med. Dośw., 2012; 66: 609–628
- Forhead A.J., Fowden A.L.: Thyroid hormones in fetal growth and prepartum maturation. J. Endocrinol., 2014; 221: R87–R103
- Franco C., Patricia H.R., Timo S., Claudia B., Marcela H.: Matrix metalloproteinases as regulators of periodontal inflammation. Int. J. Mol. Sci., 2017; 18: 440
- Fujimoto N., Zhang J., Iwata K., Shinya T., Okada Y., Hayakawa T.: A one-step sandwich enzyme immunoassay for tissue inhibitor metalloproteinases-2 using monoclonal antibodies. Clin. Chim. Acta, 1993; 220: 31–45
- Fukuda Y., Ferrans V.J., Crystal R.G.: The development of alveolar septa in fetal sheep lung. An ultrastructural and immunohistochemical study. Am. J. Anat., 1983; 167: 405–439
- Fukuda Y., Ishizaki M., Okada Y., Seiki M., Yamanaka N.: Matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in fetal rabbit lung. Am. J. Physiol. Lung. Cell. Mol. Physiol., 2000; 279: L555–L561
- Galis Z.S., Khatri J.J.: Matrix metalloproteinases in vascular remodeling and atherosclerosis: The good, the bad, and the ugly. Circ. Res., 2002; 90: 251–262
- Ganser G.L., Stricklin G.P., Matrisian L.M.: EGF and TGFα influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int. J. Dev. Biol., 1991; 35: 453–461
- Gasson J.C., Golde D.W., Kaufman S.E., Westbrook C.A., Hewick R.M., Kaufman R.J., Wong G.G., Temple P.A., Leary A.C., Brown E.L., Orr E.C., Clark S.C.: Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature, 1985; 315: 768–771
- Gill S.E., Pape M.C., Khokha R., Watson A.J., Leco K.J.: A null mutation for Tissue Inhibitor of Metalloproteinases-3 (Timp-3) impairs murine bronchiole branching morphogenesis. Dev. Biol., 2003; 261: 313–323
- Greenlee K.J., Werb Z., Kheradmand F.: Matrix metalloproteinases in lung: Multiple, multifarious, and multifaceted. Physiol. Rev., 2007; 87: 69–98
- Grenachea D.G., Gronowskib A.M.: Fetal lung maturity. Clin. Biochem., 2006; 39: 1–10
- Grodecka J., Kobos J., Zielińska-Każmierska B., Manowska B.: Evaluation of stromal proteins expression – tenastin and fibronectin – in the cysts and dental derived neoplasms of the facial part of the cranium. Wsp. Onkol., 2009; 13: 22–27
- Holm B.A., Kapur P., Irish M.S., Glick P.L.: Physiology and pathophysiology of lung development. J. Obstet Gynecol., 1997; 17: 519–527
- Hyde D.M., Tyler N.K., Putney L.F., Singh P., Gundersen H.J.: Total number and mean size of alveoli in mammalian lung estimated using fractionator sampling and unbiased estimates of the Euler characteristic of alveolar openings. Anat. Rec. A Discov. Mol. Cell. Evol. Biol., 2004; 277: 216–226
- Isnard N., Legeais J.M., Renard G., Robert L.: Effect of hyaluronan on MMP expression and activation. Cell. Biol. Int., 2001; 25: 735–739
- Joshi S., Kotecha S.: Lung growth and development. Early Hum. Dev., 2007; 83: 789–794
- Kapoor C., Vaidya S., Wadhwan V., Hitesh, Kaur G., Pathak A.: Seesaw of matrix metalloproteinases (MMPs). J. Cancer. Res. Ther., 2016; 12: 28–35
- Kheradmand F., Rishi K., Werb Z.: Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2. J. Cell. Sci., 2002; 115: 839–848
- Kim E.M., Hwang O.: Role of matrix metalloproteinase-3 in neurodegeneration. J. Neurochem., 2011; 116: 22–32
- Kim H.I., Lee H.S., Kim T.H., Lee J.S., Lee S.T., Lee S.J.: Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells. Oncotarget, 2015; 6: 42905–42922
- Kinoh H., Sato H., Tsunezuka Y., Takino T., Kawashima A., Okada Y., Seiki M.: MT-MMP, the cell surface activator of pro-MMP-2 (progelatinase A), is expressed with substrate in mouse tissue during embryogenesis. J. Cell. Sci., 1996; 109: 953–959
- Kupai K., Szucs G., Cseh S., Hajdu I., Csonka C., Csont T., Ferdinandy P.: Matrix metalloproteinase activity assays: Importance of zymography. J. Pharmacol. Toxicol. Methods, 2010; 61: 205–209
- Kurzepa J., Baran M., Wątroba S., Barud M., Babula D.: Collagenases and gelatinases in bone healing. The focus on mandibular fractures. Curr. Issues. Pharm. Med. Sci., 2014; 27: 121–126
- Lambert E., Dassé E., Haye B., Petitfrère E.: TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol., 2004; 49: 187–198
- Lamoreaux W.J., Fitzgerald M.E.C., Reiner A., Hasty K.A., Charles S.T.: Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc. Res., 1998; 55: 29–42
- Li H., Ezra D.G., Burton M.J., Bailly M.: Doxycycline prevents matrix remodeling and contraction by trichiasis-derived conjunctival fibroblasts. Invest. Ophthalmol. Vis. Sci., 2013; 54: 4675–4682
- Lipka D., Boratyński J.: Metaloproteinazy MMP. Struktura i funkcja. Postępy. Hig. Med. Dośw., 2008; 62, 328–336
- Loftus I.M., Naylor A.R., Bell P.R., Thompson M.M.: Matrix metalloproteinases and atherosclerotic plaque instability. Br. J. Surg., 2002; 89: 680–694
- Loy M., Burggraf D., Martens K.H., Liebetrau M., Wunderlich N., Bültemeier G., Nemori R., Hamann G.F.: A gelatin in situ-overlay technique localizes brain matrix metalloproteinase activity in experimental focal cerebral ischemia. J. Neurosci. Methods, 2002; 116: 125–133
- Lu Y., Papagerakis P., Yamakoshi Y., Hu J.C., Bartlett J.D., Simmer J.P.: Functions of KLK4 and MMP-20 in dental enamel formation. Biol. Chem., 2008; 389: 695–700
- Malicdem M., Taylor W., Goerke M., Devaskar U.: Ontogeny of rat lung type IV collagenase mRNA expression and collagenolytic activity during the perinatal period. Biol. Neonate, 1993; 64: 376–381
- Manicone A.M., Harju-Baker S., Johnston L.K., Chen A.J., Parks W.C.: Epilysin (matrix metalloproteinase-28) contributes to airway epithelial cell survival. Respir. Res., 2011; 12: 144
- Masumoto K., de Rooij J.D., Suita S., Rottier R., Tibboel D., de Krijger R.R.: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases during normal human pulmonary development. Histopathology, 2005; 47: 410–419
- Morancho A., Rosell A., Garcia-Bonilla L., Montaner J.: Metalloproteinase and stroke infarct size: Role for anti-inflammatory treatment? Ann. N. Y. Acad. Sci., 2010; 1207: 123–133
- Mott J.D., Werb Z.: Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell. Biol., 2004; 16: 558–564
- Murphy G., Houbrechts A., Cockett M.I., Williamson R.A., O’Shea M., Docherty A.J.: The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry, 1991; 30: 8097–8102
- Murphy G., Segain J.P., O’Shea M., Cockett M., Ioannou C., Lefebvre O., Chambon P., Basset P.: The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase. J. Biol. Chem., 1993; 268: 15435–15441
- Nagase H., Visse R., Murphy G.: Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res., 2006; 69: 562–573
- Newby A.C.: Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler. Thromb. Vasc. Biol., 2008; 28: 2108–2114
- Oblander S.A., Zhou Z., Gálvez B.G., Starcher B., Shannon J.M., Durbeej M., Arroyo A.G., Tryggvason K., Apte S.S.: Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation. Dev. Biol., 2005; 277: 255–269
- Okamoto T., Akuta T., Tamura F., van der Vliet A., Akaike T.: Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biol. Chem., 2004; 385: 997–1006
- Opdenakker G., van den Steen P.E., van Damme J.: Gelatinase B: A tuner and amplifier of immune functions. Trends Immunol., 2001; 22: 571–579
- Özenci V., Rinaldi L., Teleshova N., Matusevicius D., Kivisäkk P., Kouwenhoven M., Link H.: Metalloproteinases and their tissue inhibitors in multiple sclerosis. J. Autoimmun., 1999; 12: 297–303
- Page-McCaw A., Ewald A.J., Werb Z.: Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell. Biol., 2007; 8: 221–233
- Palosaari H., Pennington C.J., Larmas M., Edwards D.R., Tjäderhane L., Salo T.: Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) in mature human odontoblasts and pulp tissue. Eur. J. Oral. Sci., 2003; 111: 117–127
- Parks W.C., Shapiro S.D.: Matrix metalloproteinases in lung biology. Respir. Res., 2001; 2: 10–19
- Pepper M.S.: Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol., 2001; 21: 1104–1117
- Petty M.A., Wettstein J.G.: Elements of cerebral microvascular ischaemia. Brain. Res. Brain Res. Rev., 2001; 36: 23–34
- Pinkerton K.E., Joad J.P.: The mammalian respiratory system and critical windows of exposure for children’s health. Environ. Health Perspect., 2000; 108: 457–462
- Ries C.: Cytokine functions of TIMP-1. Cell. Mol. Life Sci., 2014; 71: 659–672
- Rolland G., Xu J., Dupret J.M., Post M.: Expression and characterization of type IV collagenases in rat lung cells during development. Exp. Cell Res., 1995; 218: 346–350
- Schittny J.C.: Development of the lung. Cell Tissue Res., 2017; 367: 427–444
- Schmidt R., Bültmann A., Ungerer M., Joghetaei N., Bülbül O., Thieme S., Chavakis T., Toole B.P., Gawaz M., Schömig A., May A.E.: Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: Implications in acute myocardial infarction. Circulation, 2006; 113: 834–841
- Serra P., Bruczko M., Zapico J.M., Puckowska A., Garcia M.A., Martin-Santamaria S., Ramos A., de Pascual-Teresa B.: MMP-2 selectivity in hydroxamate-type inhibitors. Curr. Med. Chem., 2012; 19: 1036–1064
- Snoek-van Beureden P.A., von den Hoff J.W.: Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Biotechniques, 2005; 38: 73–83
- Sun Q., Weber C.R., Sohail A., Bernardo M.M., Toth M., Zhao H., Turner J.R., Fridman R.: MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties. J. Biol. Chem., 2007; 282: 21998–22010
- Trojanek J.: Metaloproteinazy macierzy zewnątrzkomórkowej i ich tkankowe inhibitory. Postępy Biochem., 2012; 58: 353–362
- Tschanz S.A., Salm L.A., Roth-Kleiner M., Barré S.F., Burri P.H., Schittny J.C.: Rat lungs show a biphasic formation of new alveoli during postnatal development. J. Appl. Physiol., 2014; 117: 89–95
- van Hove I., Lemmens K., van de Velde S., Verslegers M., Moons L.: Matrix metalloproteinase-3 in the central nervous system: A look on the bright side. J. Neurochem., 2012; 123: 203–216
- Veldhuizen E.J., Haagsman H.P.: Role of pulmonary surfactant components in surface film formation and dynamics. Biochim. Biophys. Acta Biomembr., 2000; 1467: 255–270
- Verslegers M., Lemmens K., van Hove I., Moons L.: Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system. Prog. Neurobiol., 2013; 105: 60–78
- Wang X., Inoue S., Gu J., Miyoshi E., Noda K., Li W., Mizuno-Horikawa Y., Nakano M., Asahi M., Takahashi M., Uozumi N., Ihara S., Lee S.H., Ikeda Y., Yamaguchi Y., et al.: Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc. Natl. Acad. Sci. USA, 2005; 102: 15791–15796
- White S.J., Danowitz M., Solounias N.: Embryology and evolutionary history of the respiratory tract. Edorium. J. Anat. Embryo., 2016; 3: 54–62
- Woods J.C., Schittny J.C.: Lung structure at preterm and term birth. In: Fetal and Neonatal Lung Development: Clinical Correlates and Technologies for the Future, red.: A.H. Jobe, J.A. Whitsett, S.H. Abman. Cambridge University Press, Cambridge 2016, 126–140
- Wysocka A., Giziński S., Lechowski R.: Metaloproteinazy macierzy – ich struktura oraz znaczenie. Życie Weterynaryjne., 2014; 89: 223–227
- Yang J.S., Lin C.W., Su S.C., Yang S.F.: Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment. Expert Opin. Drug Metab. Toxicol., 2016; 12: 191–200
- Zhao H., Bernardo M.M., Osenkowski P., Sohail A., Pei D., Nagase H., Kashiwagi M., Soloway P.D., DeClerck Y.A., Fridman R.: Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 regulates pro-MMP-2 activation. J. Biol. Chem., 2004; 279: 8592–8601
DOI: https://doi.org/10.5604/01.3001.0014.6933 | Journal eISSN: 1732-2693
Language: English
Page range: 24 - 34
Submitted on: Jun 16, 2019
Accepted on: Jul 10, 2020
Published on: Jan 25, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2021 Sławomir Wątroba, Tomasz Wiśniowski, Jarosław Bryda, Jacek Kurzepa, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.